LncRNA HOXC-AS1 Sponges miR-99a-3p and Upregulates MMP8, Ultimately Promoting Gastric Cancer

Simple Summary Long noncoding RNAs, including the HOXC Cluster Antisense RNA 1 (HOXC-AS1), are reported to be critical during the occurrence and progression of gastric cancer. We examined cells and tissues for the expression of HOXC-AS1 and correlated the expression levels with the disease specific survival of the gastric cancer patients. We also identified the interaction between HOXC-AS1 and miR-99a-3p, as well as matrix metalloproteinase 8 (MMP8) by dual-luciferase reporter gene assays. Western blot and qRT-PCR were conducted to verify the alteration in expression levels, while Cell Counting Kit-8 assay and colony formation assay were performed to explore the influences on gastric cancer cells. Overexpression of HOXC-AS1 would accordingly sponge greater quantities of miR-99a-3p, leading to the upregulation of MMP8, eventually facilitating the progress of gastric cancer. Abstract Gastric cancer (GC) is among the most lethal tumors worldwide. Long noncoding RNAs (lncRNAs) are reported to be critical during the occurrence and progression of malignancies. The HOXC cluster antisense RNA 1 (HOXC-AS1) has been suggested to participate in the genesis and development of GC. Therefore, we examined GC cells and tissues for the expression of HOXC-AS1 and correlated the expression levels with the disease specific survival of the patients, finding that HOXC-AS1 was overexpressed and probably had a tendency of leading to a poor prognosis. The Cell Counting Kit-8 assay and colony formation assay were then performed under knockdown of HOXC-AS1, revealing that cell proliferation of GC was distinctly decreased. Afterwards, miR-99a-3p was predicted to bind with HOXC-AS1 by DIANA tools. We carried out dual-luciferase reporter gene assays to identify the interaction between them. After knockdown of HOXC-AS1, miR-99a-3p was clearly overexpressed in GC cells. In addition, matrix metalloproteinase 8 (MMP8) was shown to be combined with miR-99a-3p using TargetScan. Similar experiments, along with western blot, were conducted to validate the correlation between miR-99a-3p and MMP8. Finally, rescue experiments for CCK-8 were completed, disclosing that HOXC-AS1 promoted cell progression of GC through sponging miR-99a-3p followed by subsequent upregulation of MMP8.

[1]  Xiaobin Wu,et al.  c-Myc-activated intronic miR-210 and lncRNA MIR210HG synergistically promote the metastasis of gastric cancer. , 2021, Cancer letters.

[2]  Wei Zhao,et al.  LncRNA FEZF1-AS1 Promotes Multi-Drug Resistance of Gastric Cancer Cells via Upregulating ATG5 , 2021, Frontiers in Cell and Developmental Biology.

[3]  Yiqing Zheng,et al.  LncRNA HOXC-AS1 promotes nasopharyngeal carcinoma (NPC) progression by sponging miR-4651 and subsequently upregulating FOXO6. , 2021, Journal of pharmacological sciences.

[4]  Zhi-da Chen,et al.  Recent Advances in the Diagnosis, Staging, Treatment, and Prognosis of Advanced Gastric Cancer: A Literature Review , 2021, Frontiers in Medicine.

[5]  Xue Zhu,et al.  MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization. , 2021, Acta Biochimica et Biophysica Sinica.

[6]  L. Xin,et al.  Transfer of LncRNA CRNDE in TAM‐derived exosomes is linked with cisplatin resistance in gastric cancer , 2021, EMBO reports.

[7]  Bo Sun,et al.  LncRNA SLCO4A1-AS1 Accelerates Growth and Metastasis of Gastric Cancer via Regulation of the miR-149/XIAP Axis , 2021, Frontiers in Oncology.

[8]  Y. Kang,et al.  Hypoxia associated lncRNA HYPAL promotes proliferation of gastric cancer as ceRNA by sponging miR-431-5p to upregulate CDK14 , 2021, Gastric Cancer.

[9]  C. Maher,et al.  Long noncoding RNAs in cancer metastasis , 2021, Nature Reviews Cancer.

[10]  Bingya Liu,et al.  LncRNA MALAT1 promotes gastric cancer progression via inhibiting autophagic flux and inducing fibroblast activation , 2021, Cell Death & Disease.

[11]  Jie Wu,et al.  Global Patterns and Trends in Gastric Cancer Incidence Rates (1988-2012) and Predictions to 2030. , 2021, Gastroenterology.

[12]  B. Badgwell,et al.  Current treatment and recent progress in gastric cancer , 2021, CA: a cancer journal for clinicians.

[13]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[14]  Hongyun Wang,et al.  Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas , 2021, Cell Biology and Toxicology.

[15]  A. Sharafi,et al.  NANOG Decoy Oligodeoxynucleotide-Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme Cells. , 2020, ACS chemical neuroscience.

[16]  G. Goodall,et al.  RNA in cancer , 2020, Nature reviews. Cancer.

[17]  K. Takayama,et al.  Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors , 2020, Communications Biology.

[18]  Shanming Ruan,et al.  Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance , 2020, Molecular Cancer.

[19]  N. An,et al.  lncRNA HOXC‐AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β‐catenin signaling , 2020, The journal of gene medicine.

[20]  Jing Jia,et al.  HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer , 2019, Journal of Experimental & Clinical Cancer Research.

[21]  T. Salo,et al.  The Role of MMP8 in Cancer: A Systematic Review , 2019, International journal of molecular sciences.

[22]  Marnix Jansen,et al.  British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma , 2019, Gut.

[23]  C. Haglund,et al.  Serum MMP-8 and TIMP-1 as prognostic biomarkers in gastric cancer , 2018, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[24]  N. Seki,et al.  Regulation of NCAPG by miR‐99a‐3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC , 2018, Cancer medicine.

[25]  J. Mendell,et al.  Functional Classification and Experimental Dissection of Long Noncoding RNAs , 2018, Cell.

[26]  Long Jin,et al.  Polymorphisms in matrix metalloproteinases 2, 3, and 8 increase recurrence and mortality risk by regulating enzyme activity in gastric adenocarcinoma , 2017, Oncotarget.

[27]  Yi Lu,et al.  Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma. , 2016, Cancer letters.

[28]  Howard Y. Chang,et al.  Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.

[29]  V. Wadhwan,et al.  Seesaw of matrix metalloproteinases (MMPs). , 2016, Journal of cancer research and therapeutics.

[30]  L. Paz-Ares,et al.  MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer , 2014, BMC Cancer.

[31]  Erguang Li,et al.  A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling , 2014, Cancer biology & therapy.

[32]  D. Bartel,et al.  lincRNAs: Genomics, Evolution, and Mechanisms , 2013, Cell.

[33]  A. Cervantes,et al.  The treatment of advanced gastric cancer: current strategies and future perspectives. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  X. Puente,et al.  Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. , 2008, Cancer research.

[35]  C. López-Otín,et al.  Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer , 2008, British Journal of Cancer.

[36]  Sanne Kuijper,et al.  Regulation of angiogenesis by Eph-ephrin interactions. , 2007, Trends in cardiovascular medicine.

[37]  R. Sakai,et al.  The C-terminus of ephrin-B1 regulates metalloproteinase secretion and invasion of cancer cells , 2007, Journal of Cell Science.

[38]  D. Troyer,et al.  Neutrophil collagenase (MMP-8) is expressed during early development in neural crest cells as well as in adult melanoma cells. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[39]  J. Varani,et al.  Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin , 2000, British Journal of Cancer.